 | |||||
| in | |||||
| WEB | |||||
| Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class ... In ongoing Phase 1/2 clinical studies, OM336 has demonstrated transformative efficacy and a differentiated safety profile after a single treatment ...
| |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
ShareThis
No comments:
Post a Comment